Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arzoxifene dose evaluation in advanced breast cancer
NCT00003428Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- May 1998
- Primary completion
- Jun 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of arzoxifene in breast cancer, sponsored by Memorial Sloan Kettering Cancer Center. Started May 1998; status: completed.
02
Drugs
arzoxifene
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00003428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003428.